Compare TVRD & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TVRD | USIO |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.3M | 36.9M |
| IPO Year | N/A | N/A |
| Metric | TVRD | USIO |
|---|---|---|
| Price | $4.37 | $1.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $51.67 | $4.00 |
| AVG Volume (30 Days) | ★ 109.7K | 49.7K |
| Earning Date | 02-21-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $83,710,461.00 |
| Revenue This Year | N/A | $5.99 |
| Revenue Next Year | N/A | $11.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.46 |
| 52 Week Low | $3.74 | $1.24 |
| 52 Week High | $43.65 | $2.39 |
| Indicator | TVRD | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 47.29 |
| Support Level | $4.39 | $1.34 |
| Resistance Level | $4.89 | $1.40 |
| Average True Range (ATR) | 0.31 | 0.03 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 43.63 | 40.00 |
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.